Table 1.
Causes of end-stage renal diseases in new patients
| Causes | % |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1992 | 1994 | 1996 | 1998 | 2000 | 2002 | 2004 | 2006 | 2008 | 2009 | 2010 | 2011 | 2012 | |
| Chronic glomerulonephritis | 25.3 | 25.5 | 21.6 | 17.9 | 14.0 | 13.9 | 12.5 | 13.0 | 12.1 | 11.1 | 11.3 | 10.4 | 8.1 |
| Not histologically confirmed | 19.7 | 20.4 | 16.7 | 13.6 | 10.6 | 10.0 | 8.6 | 9.0 | 8.2 | 7.5 | 7.7 | 6.9 | 4.5 |
| Histologically confirmed | 5.6 | 5.0 | 4.9 | 4.3 | 3.4 | 3.9 | 3.9 | 3.9 | 3.8 | 3.6 | 3.6 | 3.5 | 3.6 |
| Diabetic nephropathy | 19.5 | 26.1 | 30.8 | 38.9 | 40.7 | 40.7 | 43.4 | 42.3 | 41.9 | 45.4 | 45.2 | 47.1 | 50.6 |
| Hypertensive nephrosclerosis | 15.4 | 20.8 | 18.3 | 17.8 | 16.6 | 16.0 | 16.2 | 16.9 | 18.7 | 18.3 | 19.2 | 19.6 | 18.5 |
| Cystic kidney disease | 2.1 | 2.2 | 1.8 | 1.7 | 2.2 | 1.6 | 1.4 | 1.7 | 1.7 | 1.8 | 1.7 | 1.6 | 1.8 |
| Renal tuberculosis | 1.1 | 1.5 | 1.2 | 0.5 | 0.4 | 0.5 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.0 |
| Pyelo/interstitial nephritis | 1.3 | 1.1 | 0.7 | 1.0 | 0.8 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.4 | 0.4 | 0.5 |
| Drugs or nephrotoxic agents | 1.3 | 0.1 | 0.6 | 0.3 | 0.3 | 0.4 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.5 | 0.4 |
| Lupus nephritis | 0.8 | 0.7 | 1.0 | 0.5 | 0.9 | 0.8 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.6 |
| Gouty nephropathy | 0.7 | 0.7 | 0.6 | 0.5 | 0.7 | 0.4 | 0.5 | 0.3 | 0.3 | 0.3 | 0.4 | 0.2 | 0.3 |
| Hereditary nephropathy | 0.3 | 0.7 | 0.4 | 0.2 | 0.1 | 0.2 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.5 |
| Kidney tumor | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 |
| Other | 4.1 | 2.7 | 2.8 | 3.9 | 3.0 | 5.6 | 5.9 | 6.0 | 5.8 | 5.2 | 5.1 | 5.0 | 6.8 |
| Uncertain | 28.6 | 17.8 | 15.9 | 16.6 | 20.2 | 19.0 | 17.8 | 17.5 | 17.6 | 16.0 | 15.3 | 14.3 | 11.4 |